Merck· @Merck · X·· 2026-07-24AI 评分22
AI 导读
今天我们公布了在研HIV暴露前预防（PrEP）的初步上市后准入计划。我们正在加快准入规划，以帮助确保一旦获得监管机构批准，这一HIV预防选择能迅速惠及中低收入国家有需要的人群。 了解更多：https://go.merck.com/~5hd
正文
Today we announced our initial post-approval access plans for our investigational HIV pre-exposure prophylaxis (PrEP). We are accelerating our access planning to help ensure that, if approved by the regulatory agency, this HIV prevention option can quickly reach those who need it in low- and middle-income countries.
Learn more: https://go.merck.com/~5hd
来源：Merck · x.com